Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Bryant

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Metabolic Brain Disease|December 1, 1994
Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathyS D Taylor-Robinson, J Sargentoni, C D Marcus, et al.
AJR. American Journal of Roentgenology|December 1, 1984
Magnetic resonance imaging of the kidneysA W Leung, G M Bydder, R E Steiner, et al.
Metabolic Brain Disease|November 6, 1998
Localised cerebral phosphorus-31 MR spectroscopy in man before and immediately after coronary bypass surgery with hypothermic cardiopulmonary bypassJ A Wilson, S D Taylor-Robinson, D J Bryant, et al.
Developmental Medicine and Child Neurology|June 1, 1993
Proton spectroscopy of the neonatal brain following hypoxic-ischaemic injuryC J Peden, M A Rutherford, J Sargentoni, et al.
NMR in Biomedicine|April 1, 1989
31P magnetic resonance spectroscopy of the normal human brain: approaches using four dimensional chemical shift imaging and phase mapping techniquesG A Coutts, D J Bryant, A G Collins, et al.
NMR in Biomedicine|April 1, 1990
31P magnetic resonance spectroscopy of the human paediatric liverR A Iles, I J Cox, J D Bell, et al.
Journal of Computer Assisted Tomography|September 1, 1988
Analysis of the magnitude of susceptibility effects in disease of the brain: implications for MR spectroscopyA G Collins, D J Bryant, I R Young, et al.
Journal of Computer Assisted Tomography|March 1, 1985
Gadolinium-DTPA as a contrast agent in MR imaging--theoretical projections and practical observationsD G Gadian, J A Payne, D J Bryant, et al.
Journal of Computer Assisted Tomography|September 1, 1988
Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non-Hodgkin lymphomaD J Bryant, G M Bydder, H A Case, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1996
Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theoryS D Taylor-Robinson, R A Weeks, D J Bryant, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Metabolic Brain Disease|December 1, 1994
Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathyS D Taylor-Robinson, J Sargentoni, C D Marcus, et al.
AJR. American Journal of Roentgenology|December 1, 1984
Magnetic resonance imaging of the kidneysA W Leung, G M Bydder, R E Steiner, et al.
Metabolic Brain Disease|November 6, 1998
Localised cerebral phosphorus-31 MR spectroscopy in man before and immediately after coronary bypass surgery with hypothermic cardiopulmonary bypassJ A Wilson, S D Taylor-Robinson, D J Bryant, et al.
Developmental Medicine and Child Neurology|June 1, 1993
Proton spectroscopy of the neonatal brain following hypoxic-ischaemic injuryC J Peden, M A Rutherford, J Sargentoni, et al.
NMR in Biomedicine|April 1, 1989
31P magnetic resonance spectroscopy of the normal human brain: approaches using four dimensional chemical shift imaging and phase mapping techniquesG A Coutts, D J Bryant, A G Collins, et al.
NMR in Biomedicine|April 1, 1990
31P magnetic resonance spectroscopy of the human paediatric liverR A Iles, I J Cox, J D Bell, et al.
Journal of Computer Assisted Tomography|September 1, 1988
Analysis of the magnitude of susceptibility effects in disease of the brain: implications for MR spectroscopyA G Collins, D J Bryant, I R Young, et al.
Journal of Computer Assisted Tomography|March 1, 1985
Gadolinium-DTPA as a contrast agent in MR imaging--theoretical projections and practical observationsD G Gadian, J A Payne, D J Bryant, et al.
Journal of Computer Assisted Tomography|September 1, 1988
Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non-Hodgkin lymphomaD J Bryant, G M Bydder, H A Case, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1996
Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theoryS D Taylor-Robinson, R A Weeks, D J Bryant, et al.
Pageof 6